Insurance Companies Express Caution Over Trump Administration's Medicare Weight-Loss Drug Coverage Plan

Health insurers have questioned the Trump administration's plan to include weight-loss drugs in Medicare and doubt whether enough insurers will join to ensure the program launches as intended.

CVS Health has declined to participate in the weight-loss drug coverage plan, while UnitedHealth Group has expressed skepticism about the effort, citing "significant challenges and unresolved issues" with the plan's structure.

The government's plan would require insurers to cover weight-loss medications under Medicare, potentially costing health insurers billions of dollars in the first year and forcing them to raise premiums for Medicare prescription drug plans. (Bloomberg)